Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR1 | P11362 | 1/20 | 0.50 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.49 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | TNF | P01375 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 4/20 | 0.47 |
| ▸ | RAB9A | P51151 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | GABRP | O00591 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19911341 | 0.86 | CYP11B1 (0.49) | FGFR1CYP11B1CYP11B2SMN1; SMN2LMNA | |
| SCHEMBL10600757 | 0.84 | NPC1 (0.62) | FGFR1CYP11B1CYP11B2SMN1; SMN2LMNA | |
| SCHEMBL13559830 | 0.83 | CYP11B1 (0.71) | CYP11B1CYP11B2SMN1; SMN2LMNAHTT | |
| SCHEMBL20125126 | 0.83 | MAPT (0.53) | FGFR1CYP11B1CYP11B2SMN1; SMN2LMNA | |
| SCHEMBL18250758 | 0.83 | POLB (0.66) | FGFR1CYP11B1CYP11B2SMN1; SMN2LMNA | |
| SCHEMBL19296053 | 0.81 | LMNA (0.53) | FGFR1SMN1; SMN2LMNAHTTTNF | |
| SCHEMBL21378150 | 0.81 | MAPT (0.58) | FGFR1CYP11B1CYP11B2SMN1; SMN2LMNA | |
| SCHEMBL11085471 | 0.80 | MAPT (0.58) | FGFR1CYP11B1CYP11B2SMN1; SMN2LMNA | |
| SCHEMBL18250746 | 0.80 | MAPT (0.46) | FGFR1CYP11B1CYP11B2SMN1; SMN2LMNA | |
| SCHEMBL15345067 | 0.80 | CYP11B1 (0.68) | FGFR1CYP11B1CYP11B2SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180062213-A1 | Nonaqueous Electrolyte and Nonaqueous Secondary Battery | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2018-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180062213-A1 | Nonaqueous Electrolyte and Nonaqueous Secondary Battery | BPTF, BRD4, KCNN2 | FGFR1 1543/4885CYP11B1 640/4885CYP11B2 607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.